nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—Hostility—Thalidomide—leprosy	0.0232	0.0232	CcSEcCtD
Gatifloxacin—Vesiculobullous rash—Thalidomide—leprosy	0.0229	0.0229	CcSEcCtD
Gatifloxacin—Myasthenia—Thalidomide—leprosy	0.0205	0.0205	CcSEcCtD
Gatifloxacin—Oral candidiasis—Thalidomide—leprosy	0.0202	0.0202	CcSEcCtD
Gatifloxacin—Cyanosis—Thalidomide—leprosy	0.0182	0.0182	CcSEcCtD
Gatifloxacin—Metrorrhagia—Thalidomide—leprosy	0.018	0.018	CcSEcCtD
Gatifloxacin—Psychotic disorder—Dapsone—leprosy	0.0178	0.0178	CcSEcCtD
Gatifloxacin—Hyperaesthesia—Thalidomide—leprosy	0.0164	0.0164	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Dapsone—leprosy	0.0163	0.0163	CcSEcCtD
Gatifloxacin—Rash pustular—Thalidomide—leprosy	0.0161	0.0161	CcSEcCtD
Gatifloxacin—Muscular weakness—Dapsone—leprosy	0.0161	0.0161	CcSEcCtD
Gatifloxacin—Pancreatitis—Dapsone—leprosy	0.0154	0.0154	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Dapsone—leprosy	0.0144	0.0144	CcSEcCtD
Gatifloxacin—Thinking abnormal—Thalidomide—leprosy	0.014	0.014	CcSEcCtD
Gatifloxacin—Bone pain—Thalidomide—leprosy	0.0134	0.0134	CcSEcCtD
Gatifloxacin—Neck pain—Thalidomide—leprosy	0.013	0.013	CcSEcCtD
Gatifloxacin—Pharyngitis—Dapsone—leprosy	0.0125	0.0125	CcSEcCtD
Gatifloxacin—Colitis—Thalidomide—leprosy	0.0123	0.0123	CcSEcCtD
Gatifloxacin—Candida infection—Thalidomide—leprosy	0.0123	0.0123	CcSEcCtD
Gatifloxacin—Dry eye—Thalidomide—leprosy	0.0119	0.0119	CcSEcCtD
Gatifloxacin—Cramps of lower extremities—Thalidomide—leprosy	0.0118	0.0118	CcSEcCtD
Gatifloxacin—Tinnitus—Dapsone—leprosy	0.0118	0.0118	CcSEcCtD
Gatifloxacin—Rash maculo-papular—Thalidomide—leprosy	0.0117	0.0117	CcSEcCtD
Gatifloxacin—Hypertonia—Thalidomide—leprosy	0.0113	0.0113	CcSEcCtD
Gatifloxacin—Mental disability—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Gatifloxacin—Euphoric mood—Thalidomide—leprosy	0.011	0.011	CcSEcCtD
Gatifloxacin—Erythema—Dapsone—leprosy	0.011	0.011	CcSEcCtD
Gatifloxacin—Lymphadenopathy—Thalidomide—leprosy	0.0109	0.0109	CcSEcCtD
Gatifloxacin—Diabetes mellitus—Thalidomide—leprosy	0.0107	0.0107	CcSEcCtD
Gatifloxacin—Photosensitivity—Thalidomide—leprosy	0.0106	0.0106	CcSEcCtD
Gatifloxacin—Vision blurred—Dapsone—leprosy	0.0103	0.0103	CcSEcCtD
Gatifloxacin—Eye pain—Thalidomide—leprosy	0.0103	0.0103	CcSEcCtD
Gatifloxacin—Renal failure acute—Thalidomide—leprosy	0.0101	0.0101	CcSEcCtD
Gatifloxacin—Vertigo—Dapsone—leprosy	0.00986	0.00986	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Thalidomide—leprosy	0.00977	0.00977	CcSEcCtD
Gatifloxacin—Arthritis—Thalidomide—leprosy	0.0096	0.0096	CcSEcCtD
Gatifloxacin—Hypoglycaemia—Thalidomide—leprosy	0.00956	0.00956	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00933	0.00933	CcSEcCtD
Gatifloxacin—Migraine—Thalidomide—leprosy	0.00919	0.00919	CcSEcCtD
Gatifloxacin—Psychotic disorder—Thalidomide—leprosy	0.00911	0.00911	CcSEcCtD
Gatifloxacin—Face oedema—Thalidomide—leprosy	0.00901	0.00901	CcSEcCtD
Gatifloxacin—Ataxia—Thalidomide—leprosy	0.00878	0.00878	CcSEcCtD
Gatifloxacin—Tachycardia—Dapsone—leprosy	0.00875	0.00875	CcSEcCtD
Gatifloxacin—Dry skin—Thalidomide—leprosy	0.00855	0.00855	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Thalidomide—leprosy	0.00823	0.00823	CcSEcCtD
Gatifloxacin—Muscular weakness—Thalidomide—leprosy	0.00823	0.00823	CcSEcCtD
Gatifloxacin—Insomnia—Dapsone—leprosy	0.0081	0.0081	CcSEcCtD
Gatifloxacin—Dysphagia—Thalidomide—leprosy	0.00807	0.00807	CcSEcCtD
Gatifloxacin—Bronchospasm—Thalidomide—leprosy	0.00793	0.00793	CcSEcCtD
Gatifloxacin—Pancreatitis—Thalidomide—leprosy	0.00791	0.00791	CcSEcCtD
Gatifloxacin—Neutropenia—Thalidomide—leprosy	0.00754	0.00754	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Thalidomide—leprosy	0.00736	0.00736	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Dapsone—leprosy	0.00733	0.00733	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Thalidomide—leprosy	0.00728	0.00728	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00713	0.00713	CcSEcCtD
Gatifloxacin—Body temperature increased—Dapsone—leprosy	0.00708	0.00708	CcSEcCtD
Gatifloxacin—Abdominal pain—Dapsone—leprosy	0.00708	0.00708	CcSEcCtD
Gatifloxacin—Stomatitis—Thalidomide—leprosy	0.00701	0.00701	CcSEcCtD
Gatifloxacin—Conjunctivitis—Thalidomide—leprosy	0.00699	0.00699	CcSEcCtD
Gatifloxacin—Sweating—Thalidomide—leprosy	0.0069	0.0069	CcSEcCtD
Gatifloxacin—Haematuria—Thalidomide—leprosy	0.00686	0.00686	CcSEcCtD
Gatifloxacin—Epistaxis—Thalidomide—leprosy	0.00678	0.00678	CcSEcCtD
Gatifloxacin—Bradycardia—Thalidomide—leprosy	0.00657	0.00657	CcSEcCtD
Gatifloxacin—Hepatitis—Thalidomide—leprosy	0.00646	0.00646	CcSEcCtD
Gatifloxacin—Pharyngitis—Thalidomide—leprosy	0.00641	0.00641	CcSEcCtD
Gatifloxacin—Oedema peripheral—Thalidomide—leprosy	0.00636	0.00636	CcSEcCtD
Gatifloxacin—Visual impairment—Thalidomide—leprosy	0.00622	0.00622	CcSEcCtD
Gatifloxacin—Erythema multiforme—Thalidomide—leprosy	0.0061	0.0061	CcSEcCtD
Gatifloxacin—Eye disorder—Thalidomide—leprosy	0.00603	0.00603	CcSEcCtD
Gatifloxacin—Tinnitus—Thalidomide—leprosy	0.00602	0.00602	CcSEcCtD
Gatifloxacin—Chills—Thalidomide—leprosy	0.00579	0.00579	CcSEcCtD
Gatifloxacin—Vomiting—Dapsone—leprosy	0.0057	0.0057	CcSEcCtD
Gatifloxacin—Headache—Dapsone—leprosy	0.00561	0.00561	CcSEcCtD
Gatifloxacin—Flatulence—Thalidomide—leprosy	0.00554	0.00554	CcSEcCtD
Gatifloxacin—Tension—Thalidomide—leprosy	0.00552	0.00552	CcSEcCtD
Gatifloxacin—Dysgeusia—Thalidomide—leprosy	0.0055	0.0055	CcSEcCtD
Gatifloxacin—Nervousness—Thalidomide—leprosy	0.00546	0.00546	CcSEcCtD
Gatifloxacin—Back pain—Thalidomide—leprosy	0.00544	0.00544	CcSEcCtD
Gatifloxacin—Muscle spasms—Thalidomide—leprosy	0.0054	0.0054	CcSEcCtD
Gatifloxacin—Nausea—Dapsone—leprosy	0.00532	0.00532	CcSEcCtD
Gatifloxacin—Vision blurred—Thalidomide—leprosy	0.0053	0.0053	CcSEcCtD
Gatifloxacin—Tremor—Thalidomide—leprosy	0.00527	0.00527	CcSEcCtD
Gatifloxacin—Agitation—Thalidomide—leprosy	0.00517	0.00517	CcSEcCtD
Gatifloxacin—Angioedema—Thalidomide—leprosy	0.00514	0.00514	CcSEcCtD
Gatifloxacin—Vertigo—Thalidomide—leprosy	0.00505	0.00505	CcSEcCtD
Gatifloxacin—Syncope—Thalidomide—leprosy	0.00504	0.00504	CcSEcCtD
Gatifloxacin—Palpitations—Thalidomide—leprosy	0.00497	0.00497	CcSEcCtD
Gatifloxacin—Loss of consciousness—Thalidomide—leprosy	0.00494	0.00494	CcSEcCtD
Gatifloxacin—Convulsion—Thalidomide—leprosy	0.00487	0.00487	CcSEcCtD
Gatifloxacin—Hypertension—Thalidomide—leprosy	0.00485	0.00485	CcSEcCtD
Gatifloxacin—Myalgia—Thalidomide—leprosy	0.00479	0.00479	CcSEcCtD
Gatifloxacin—Chest pain—Thalidomide—leprosy	0.00479	0.00479	CcSEcCtD
Gatifloxacin—Arthralgia—Thalidomide—leprosy	0.00479	0.00479	CcSEcCtD
Gatifloxacin—Anxiety—Thalidomide—leprosy	0.00477	0.00477	CcSEcCtD
Gatifloxacin—Confusional state—Thalidomide—leprosy	0.00463	0.00463	CcSEcCtD
Gatifloxacin—Oedema—Thalidomide—leprosy	0.00459	0.00459	CcSEcCtD
Gatifloxacin—Infection—Thalidomide—leprosy	0.00456	0.00456	CcSEcCtD
Gatifloxacin—Shock—Thalidomide—leprosy	0.00451	0.00451	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Thalidomide—leprosy	0.00449	0.00449	CcSEcCtD
Gatifloxacin—Tachycardia—Thalidomide—leprosy	0.00448	0.00448	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Thalidomide—leprosy	0.00443	0.00443	CcSEcCtD
Gatifloxacin—Anorexia—Thalidomide—leprosy	0.00437	0.00437	CcSEcCtD
Gatifloxacin—Hypotension—Thalidomide—leprosy	0.00429	0.00429	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Thalidomide—leprosy	0.00418	0.00418	CcSEcCtD
Gatifloxacin—Insomnia—Thalidomide—leprosy	0.00415	0.00415	CcSEcCtD
Gatifloxacin—Paraesthesia—Thalidomide—leprosy	0.00412	0.00412	CcSEcCtD
Gatifloxacin—Dyspnoea—Thalidomide—leprosy	0.00409	0.00409	CcSEcCtD
Gatifloxacin—Somnolence—Thalidomide—leprosy	0.00408	0.00408	CcSEcCtD
Gatifloxacin—Dyspepsia—Thalidomide—leprosy	0.00404	0.00404	CcSEcCtD
Gatifloxacin—Decreased appetite—Thalidomide—leprosy	0.00399	0.00399	CcSEcCtD
Gatifloxacin—Constipation—Thalidomide—leprosy	0.00392	0.00392	CcSEcCtD
Gatifloxacin—Feeling abnormal—Thalidomide—leprosy	0.00378	0.00378	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Thalidomide—leprosy	0.00375	0.00375	CcSEcCtD
Gatifloxacin—Urticaria—Thalidomide—leprosy	0.00364	0.00364	CcSEcCtD
Gatifloxacin—Abdominal pain—Thalidomide—leprosy	0.00363	0.00363	CcSEcCtD
Gatifloxacin—Body temperature increased—Thalidomide—leprosy	0.00363	0.00363	CcSEcCtD
Gatifloxacin—Hypersensitivity—Thalidomide—leprosy	0.00338	0.00338	CcSEcCtD
Gatifloxacin—Asthenia—Thalidomide—leprosy	0.00329	0.00329	CcSEcCtD
Gatifloxacin—Pruritus—Thalidomide—leprosy	0.00325	0.00325	CcSEcCtD
Gatifloxacin—Diarrhoea—Thalidomide—leprosy	0.00314	0.00314	CcSEcCtD
Gatifloxacin—Dizziness—Thalidomide—leprosy	0.00303	0.00303	CcSEcCtD
Gatifloxacin—Vomiting—Thalidomide—leprosy	0.00292	0.00292	CcSEcCtD
Gatifloxacin—Rash—Thalidomide—leprosy	0.00289	0.00289	CcSEcCtD
Gatifloxacin—Dermatitis—Thalidomide—leprosy	0.00289	0.00289	CcSEcCtD
Gatifloxacin—Headache—Thalidomide—leprosy	0.00287	0.00287	CcSEcCtD
Gatifloxacin—Nausea—Thalidomide—leprosy	0.00272	0.00272	CcSEcCtD
